Cargando…
A Rare Case of Small Cell Lung Cancer With an Epidermal Growth Factor Receptor Mutation and Its Response to Osimertinib
Small cell lung cancer (SCLC) accounts for less than 15% of the cases of lung cancer. Epidermal growth factor receptor (EGFR) mutations are rarely reported in association with SCLC. EGFR tyrosine kinase inhibitors (TKI) are approved as the first-line therapy for metastatic non-small cell lung cancer...
Autores principales: | Bhuiyan, Sakil, Siddiqui, Raheel S, Zirkiyeva, Milana, Agladze, Mariam, Bashir, Tayyaba |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214366/ https://www.ncbi.nlm.nih.gov/pubmed/34164239 http://dx.doi.org/10.7759/cureus.15136 |
Ejemplares similares
-
Hemophagocytic Lymphohistiocytosis as the Presenting Manifestation of Relapsed Classic Hodgkin’s Lymphoma in the Presence of Concurrent Human Immunodeficiency Virus, Genital Herpes, Epstein-Barr Virus and Mycobacterium Avium Complex Infection
por: Siddiqui, Raheel S, et al.
Publicado: (2020) -
Lactulose-Induced Ischemic Colitis: A Rare Presentation and an Overview of Possible Etiologies of the Disease
por: Umar, Zaryab, et al.
Publicado: (2022) -
Macrophage Activation Syndrome Upon Initiation of Adalimumab in a Patient With Longstanding Rheumatoid Arthritis
por: Chicos, Celestin, et al.
Publicado: (2021) -
Onset of Ketosis-Prone Diabetes in the Setting of COVID-19 Infection
por: Siddiqui, Raheel S, et al.
Publicado: (2020) -
Identification of Epidermal Growth Factor Receptor Tyrosine-Kinase Mutations in Non-small Cell Lung Cancer: Testing Platform Matters
por: Gandhi, Shipra, et al.
Publicado: (2020)